Tremelimumab (anti-CTLA-4)Tremelimumab (anti-CTLA-4)
Move your mouse over image or click to enlarge

Tremelimumab (anti-CTLA-4)

Tremelimumab (Ticilimumab, CP-675,206) is a fully human monoclonal antibody that binds to cytotoxic T-lymphocyte-associated protein 4 (CTLA-4) on the surface of activated T lymphocytes.
Cat# Size Price Qty Buy
A2021-1mg*25 1mg*25
£2,432.00
A2021-1mg*5 1mg*5
£800.00
A2021-1mg 1mg
£243.00

Additional Information

Property Value or Rating
Manufacturer Selleck Chemicals LLC
Manufacturer Cat# A2021

Related Documents